Intellia Therapeutics, Inc. · 1 day ago
Senior Accountant
Cambridge, MA
Full-time
Hybrid
Mid, Senior Level
$94K/yr - $116K/yr
3+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Senior Accountant will play a crucial role in maintaining the integrity of the General Ledger and ensuring the efficiency of the month-end close cycle, requiring strong technical accounting skills and attention to detail.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Support the full cycle month-end, quarter-end, and year-end close processes, ensuring all financial deadlines are met accurately and efficiently
Prepare and post complex journal entries across various accounts, including R&D and G&A accruals, prepaid amortization, fixed assets, and others as necessary
Perform detailed and timely reconciliations of all assigned Balance Sheet accounts, investigating and resolving all discrepancies promptly
Conduct thorough P&L and Balance Sheet flux analyses, providing clear, documented explanations for variances compared to prior periods
Serve as a key contact for external auditors during quarterly reviews and the annual audit, preparing required supporting schedules and documentation
Manage the accounting for Fixed Assets and related capital expenditure tracking and tagging, ensuring proper capitalization and disposal procedures are followed
Ensure all general ledger activities and account reconciliations are performed in compliance with US GAAP
Maintain and update documentation for internal controls over financial reporting (SOX 404), specifically for general ledger and operational cycles (e.g. fixed assets)
Execute and document periodic testing of assigned SOX controls to ensure operating effectiveness
Work with R&D employees to adhere to monthly time reporting requirements
Actively participate in the maintenance and optimization of the company's ERP system and other financial tools, focusing on streamlining the close process
Identify opportunities for automation and efficiency gains within daily and monthly accounting tasks
Develop and maintain robust, comprehensive standard operating procedures (SOPs) for key responsibilities
Assist with additional projects, system implementations, integrations, and upgrades
Qualification
Required
Bachelor's degree in accounting or finance
Prior experience in a publicly traded company is required
3+ years of progressive experience in accounting/finance experience
Detail-oriented with high standards for accuracy and data integrity
Excellent ability to manage competing deadlines and priorities in a fast-paced, dynamic environment
Strong analytical and problem-solving skills
Effective written and verbal communication skills to interact across all levels of the organization
Intellectual curiosity with the ability to problem solve with minimal oversight
Proficient with Accounting software (e.g. Oracle, FloQast) and advanced Excel skills (e.g. pivot tables, XLOOKUP, etc.)
Experience in a public company environment and familiarity with SOX compliance and ERP systems are essential
Preferred
Certified Public Accountant (CPA) preferred
Experience in the Biotechnology or Pharmaceutical industry preferred
Experience in Big 4 accounting firms a plus
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
Labiotech UG
2026-01-22
Clinical Trials Arena
2026-01-16
Company data provided by crunchbase